Multicenter Phase II Study of Transanal TME (taTME)

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

April 12, 2022

Study Completion Date

April 30, 2027

Conditions
Rectal CancerSurgery
Interventions
PROCEDURE

Transanal Total Mesorectal Excision (taTME)

Study procedures consist in 1-team (sequential) or 2-team (combined) low anterior resection with transanal TME using laparoscopic or robotic abdominal assistance.

Trial Locations (12)

10003

Mount Sinai Beth Israel, New York

10029

Icahn School of Medicine at Mount Sinai, New York

19096

Lankenau Institute, Wynnewood

32804

Florida Hospital, Orlando

33331

Cleveland Clinic Florida, Weston

44195

Cleveland Clinic, Cleveland

90027

Kaiser Permanente, Los Angeles

90048

Cedars Sinai Medical Center, Los Angeles

92868

UC Irvine Hospital, Orange

97213

Providence Portland Medical Center, Portland

01605

University of Massachusetts, Worcester

Unknown

Toronto Western Hospital, Toronto

All Listed Sponsors
collaborator

Society of American Gastrointestinal and Endoscopic Surgeons

OTHER

collaborator

Research Foundation of the American Society of Colon and Rectal Surgeons

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03144765 - Multicenter Phase II Study of Transanal TME (taTME) | Biotech Hunter | Biotech Hunter